Guest Contributors

Simon Fredriksson, CEO and Co-founder of Pixelgen Technologies
Paul Freemont, Co-director of UK Innovation and Knowledge Centre for Synthetic Biology at Imperial College
Director, University of Illinois, Research Park
Co-Founder, Co-CEO, Emerald Therapeutics
Columnist, Bio-IT World
Mark Gardner, CEO of Omniseq
Director, Research Programs and Operations, Amyris Inc.
Sylvain Gariel, COO of DNA Script
Russell Garlick, CSO of SeraCare
Sean George, CEO of Invitae
Researcher, Fred Hutchinson Cancer Center; CEO, Scisco Genetics
President, The Linus Group
John Gill, Senior Director of Research and Innovation at Telesis
Director, Duke Center for Applied Genomics and Precision Medicine
VP of Communications, CLC Bio
Kirstin Goldring, Principal Scientist at Astra Zeneca, Counselor at the European Society for Biopreservation and Biobanking, Member of ISBER or the International Society for Biorepositories
Brett Goldsmith, Chief Technology Officer at Cardea
Professor, UCSD
Partner, VenBio
Carla Grandori , CEO and Founder of SEngine
Professor, University of Houston
Brad Gray, CEO of NanoString
John Greally
Professor of Law, Stanford